1
Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension
Condition(s):Glaucoma; Ocular HypertensionLast Updated:March 16, 2022Not yet recruiting
Latanoprost: 255 Clinical Trials, Page 1 of 26
Hide Studies Not Open or Pending
2
Efficacy and Safety of Three Different Latanoprost 0,005% Eyedrops in Subjects Affected by Primary Open Angle Glaucoma
Condition(s):Intraocular Pressure (IOP); Tear Break-Up TimeLast Updated:April 18, 2012Unknown status
3
Study of a Latanoprost Ocular Implant for Treatment of Open Angle Glaucoma or Ocular Hypertension.
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:April 19, 2022Recruiting
4
Microneedling and Latanoprost in Acrofacial Vitiligo
Condition(s):VitiligoLast Updated:August 28, 2018Unknown status
5
MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Condition(s):Open Angle Glaucoma; Ocular HypertensionLast Updated:September 22, 2022Recruiting
6
Comparison of Preserved and Preservative-free Latanoprost 0.005% in Primary Open Angle Glaucoma and Ocular Hypertensive Patients, at Guinness Eye Centre, Lagos.
Condition(s):Effect of DrugLast Updated:November 7, 2022Recruiting
7
Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation
Condition(s):Non-segmental VitiligoLast Updated:March 23, 2021Active, not recruiting
8
Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost
Condition(s):Glaucoma; Ocular HypertensionLast Updated:February 8, 2021Completed
9
Clinical Evaluation of Safety and Efficacy of Refrigeration Free Latanoprost
Condition(s):Glaucoma, Open-Angle; Ocular HypertensionLast Updated:July 12, 2012Unknown status
10
Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension
Condition(s):Glaucoma, Open-Angle; Hypertension, OcularLast Updated:September 24, 2020Completed